Abstract
No public abstract is available from the verified source records.
Liisa L. Bergmann, Jitka Starekova, Christopher François
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
2019
Cardiovascular magnetic resonance angiography: carotids, aorta, and peripheral vessels
2019
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo
10.1038/nm0195-69 · 1995
Lesion versus lumen
10.1038/nm0195-17 · 1995
Recent advances in 3D time-resolved contrast-enhanced MR angiography
10.1002/jmri.24880 · 2015
Gadolinium retention: a research roadmap from the 2018 NIH/ACR/RSNA workshop on gadolinium chelates
10.1148/radiol.2018181151 · 2018
Chemistry of MRI contrast agents: current challenges and new frontiers
10.1021/acs.chemrev.8b00363 · 2019
Gadolinium-enhanced MR aortography
10.1148/radiology.191.1.8134563 · 1994
Magnetic resonance angiography
10.1002/0471142719.mib0700s13 · 2002
T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T
10.1097/rli.0000000000000132 · 2015
Comparison of the relaxivities of macrocyclic gadolinium-based contrast agents in human plasma at 1.5, 3, and 7 T, and blood at 3 T
10.1097/rli.0000000000000577 · 2019
Contrast material travel times in patients undergoing peripheral MR angiography
10.1148/radiol.2241011338 · 2002
Bolus arterial-venous transit in the lower extremity and venous contamination in bolus chase three-dimensional magnetic resonance angiography
10.1097/00004424-200208000-00007 · 2002
Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the American College of radiology and the national kidney foundation
10.1148/radiol.2020202903 · 2021
Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration
10.1007/s00204-021-03189-8 · 2022
Update on gadolinium based contrast agent safety, from the AJR special series on contrast media
10.2214/ajr.23.30036 · 2024
Gadofosveset-enhanced magnetic resonance angiography
10.2147/vhrm.2008.04.01.1 · 2008
Immediate allergic reactions to gadolinium-based contrast agents: a systematic review and meta-analysis
10.1148/radiol.2017162740 · 2018
Hypersensitivity reactions to iodinated contrast media: a multicenter study of 196 081 patients
10.1148/radiol.2019190485 · 2019
Allergic-like hypersensitivity reactions to gadolinium-based contrast agents: an 8-year cohort study of 154 539 patients
10.1148/radiol.210545 · 2022
Acute reactions to gadolinium-based contrast agents in a pediatric cohort: a retrospective study of 16,237 injections
10.2214/ajr.20.23602 · 2021
A systematic review of 639 patients with biopsy-confirmed nephrogenic systemic fibrosis
10.1148/radiol.2019182916 · 2019
FDA drug safety communication: FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings
2018
Unresolved referenced work
2024
Unresolved referenced work
2018
Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review and meta-analysis
10.1001/jamainternmed.2019.5284 · 2020
FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings
2017
Unresolved referenced work
2026
Symptoms associated with gadolinium exposure (SAGE): a suggested term
10.1148/radiol.2021211349 · 2022
Unresolved referenced work
Kept as external metadata until matched
Repurposing ferumoxytol: diagnostic and therapeutic applications of an FDA-approved nanoparticle
10.7150/thno.67375 · 2022
Emerging applications for ferumoxytol as a contrast agent in MRI
10.1002/jmri.24691 · 2015
Ferumoxytol-enhanced MRI in children and young adults: state of the art
10.2214/ajr.22.28453 · 2023
Comparison of gadolinium-enhanced and ferumoxytol-enhanced conventional and UTE-MRA for the depiction of the pulmonary vasculature
10.1002/mrm.27853 · 2019
Relaxivity of ferumoxytol at 1.5 T and 3.0 T
10.1097/rli.0000000000000434 · 2018
Brain iron deposition after ferumoxytol-enhanced MRI: a study of Porcine brains
10.7150/ntno.46356 · 2020
Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy
10.1177/20406207211018042 · 2021
Pulmonary MRA during pregnancy: early experience with ferumoxytol
10.1002/jmri.28504 · 2023
MRI-guided cardiac catheterization in congenital heart disease: how to get started
10.1007/s11886-022-01659-8 · doi-reference
Novel imaging techniques for the diagnosis and treatment of congenital heart defects: MR-guided interventions and beyond
10.2217/fca.11.85 · doi-reference
Magnetic resonance-guided procedures: consensus on rationale, techniques, and outcomes
10.1016/j.tvir.2023.100914 · doi-reference
White paper: interventional MRI: current status and potential for development considering economic perspectives, Part 1: general application
10.1055/s-0043-110011 · doi-reference
Three-station three-dimensional bolus-chase MR angiography with real-time fluoroscopic tracking
10.1148/radiol.14131603 · doi-reference
Subtractionless first-pass single contrast medium dose peripheral MR angiography using two-point Dixon fat suppression
10.1007/s00330-013-2833-y · doi-reference
Peripheral arterial disease: sensitivity-encoded multiposition MR angiography compared with intraarterial angiography and conventional multiposition MR angiography
10.1148/radiol.2311020845 · doi-reference
Peripheral bolus-chase MR angiography: analysis of risk factors for nondiagnostic image quality of the calf vessels--a combined retrospective and prospective study
10.2214/ajr.08.1814 · doi-reference
10.1148/radiographics.20.1.g00ja10135
10.1148/radiographics.20.1.g00ja10135 · doi-reference
Peripheral arterial occlusive disease: 3.0-T versus 1.5-T MR angiography compared with digital subtraction angiography
10.1148/radiol.12112184 · doi-reference
Peripheral vascular tree stenoses: detection with subtracted and nonsubtracted MR angiography
10.1148/radiology.206.3.9494485 · doi-reference
Non-contrast-enhanced MR angiography in critical limb ischemia: performance of quiescent-interval single-shot (QISS) and TSE-based subtraction techniques
10.1007/s00330-016-4448-6 · doi-reference
The effects of time varying intravascular signal intensity and k-space acquisition order on three-dimensional MR angiography image quality
10.1002/jmri.1880060413 · doi-reference
Do the cardiovascular risk profile and the degree of arterial wall calcification influence the performance of MDCT angiography of lower extremity arteries?
10.1007/s00330-009-1555-7 · doi-reference
Ankle brachial index <0.9 underestimates the prevalence of peripheral artery occlusive disease assessed with whole-body magnetic resonance angiography in the elderly
10.1080/02841850701732957 · doi-reference
Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review
10.1161/01.atv.0000168911.78624.b7 · doi-reference
The ankle-brachial index as a predictor of survival in patients with peripheral vascular disease
10.1007/bf02599061 · doi-reference
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis
10.1001/jama.300.2.197 · doi-reference
10.1016/j.jacc.2011.08.023
10.1016/j.jacc.2011.08.023 · doi-reference
10.1161/circulationaha.106.174526
10.1161/circulationaha.106.174526 · doi-reference
Prognostic value of cardiovascular MR imaging biomarkers on outcome in peripheral arterial disease: a 6-year follow-up pilot study
10.1007/s10554-016-0908-y · doi-reference
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
10.1016/j.jacc.2010.09.001 · doi-reference
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
10.1016/j.jacc.2013.11.005 · doi-reference
The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease
10.1016/j.ejvs.2015.10.022 · doi-reference
Prevalence and risk factors for cerebral infarction and carotid artery stenosis in peripheral arterial disease
10.1016/j.atherosclerosis.2012.05.019 · doi-reference
The ratio of ankle and arm arterial pressure as an independent predictor of mortality
10.1016/0021-9150(91)90014-t · doi-reference
Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality
10.1016/j.jacc.2008.07.060 · doi-reference
Peripheral arterial disease detection, awareness, and treatment in primary care
10.1001/jama.286.11.1317 · doi-reference
Novel markers of peripheral arterial disease
10.1177/1358863x09106869 · doi-reference
Peripheral arterial disease, prevalence and cumulative risk factor profile analysis
10.1177/2047487312452968 · doi-reference
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
10.1016/j.jvs.2006.12.037 · doi-reference
Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010
10.1016/j.gheart.2013.12.008 · doi-reference
Ethnic-specific prevalence of peripheral arterial disease in the United States
10.1016/j.amepre.2006.12.010 · doi-reference
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
10.1016/s0140-6736(13)61249-0 · doi-reference
The value of true-FISP sequence added to conventional gadolinium-enhanced MRA of abdominal aorta and its major branches
10.1016/j.ejrad.2008.09.004 · doi-reference
Computed tomography angiography and magnetic resonance angiography imaging of the mesenteric vasculature
10.1053/j.tvir.2014.12.002 · doi-reference
MR angiography: noninvasive vascular imaging of the abdomen
10.1007/s00261-001-0063-2 · doi-reference
Anatomic and radiologic review of chronic mesenteric ischemia and its treatment
10.1016/j.clinimag.2016.04.003 · doi-reference
Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the aorta and the renal and other visceral abdominal arteries
10.2214/ajr.166.4.8610584 · doi-reference
Comparison of noninvasive imaging modalities for stenosis grading in mesenteric arteries
10.1055/s-0033-1335212 · doi-reference